Dahiroc, Estrella S.
HRN: 26-90-06 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/03/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
04/03/2025
04/10/2025
IV
500 Mg
OD
HAP
Waiting Final Action